UY31513A1 - Compuestos amida como refuerzos de antivirales - Google Patents

Compuestos amida como refuerzos de antivirales

Info

Publication number
UY31513A1
UY31513A1 UY31513A UY31513A UY31513A1 UY 31513 A1 UY31513 A1 UY 31513A1 UY 31513 A UY31513 A UY 31513A UY 31513 A UY31513 A UY 31513A UY 31513 A1 UY31513 A1 UY 31513A1
Authority
UY
Uruguay
Prior art keywords
compounds
reinforcements
antiviral
certain drugs
amida
Prior art date
Application number
UY31513A
Other languages
English (en)
Inventor
Van Het Gerben Albert Klooster
Baumeister Judith Eva
Sasaki Jennifer Chiyomi
Hache Geerwin Yvonne Paul
Schepens Wim Bert Griet
Jonckers Tim Hugo Maria
Sabine Hallenberger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39386111&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY31513(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of UY31513A1 publication Critical patent/UY31513A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

La presente invencion se refiere a compuestos que tienen propiedades inhibidoras de CYP450 y por lo tanto son utiles como refuerzos de determinadas drogas, es decir, son capaces de aumentar por lo menos una de las variables farmacocinéticas de determinadas drogas cuando se co-administran. La invencion proporciona además el uso de dichos compuestos como mejoradores de la biodisponibilidad de determinadas drogas. Además se proporcionan métodos para la preparacion de los compuestos de la invencion y composiciones farmacéuticas.
UY31513A 2007-12-06 2008-12-05 Compuestos amida como refuerzos de antivirales UY31513A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07122468 2007-12-06

Publications (1)

Publication Number Publication Date
UY31513A1 true UY31513A1 (es) 2009-07-17

Family

ID=39386111

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31513A UY31513A1 (es) 2007-12-06 2008-12-05 Compuestos amida como refuerzos de antivirales

Country Status (24)

Country Link
US (1) US8350048B2 (es)
EP (1) EP2235008B1 (es)
JP (1) JP5509092B2 (es)
KR (1) KR101624675B1 (es)
CN (1) CN101878210B (es)
AP (1) AP2804A (es)
AR (1) AR069595A1 (es)
AU (1) AU2008333165B2 (es)
BR (1) BRPI0821021A2 (es)
CA (1) CA2706155C (es)
CL (1) CL2008003639A1 (es)
EA (1) EA019616B1 (es)
HK (1) HK1149553A1 (es)
IL (1) IL205489A (es)
MX (1) MX2010006166A (es)
MY (1) MY151005A (es)
NZ (1) NZ585652A (es)
PA (1) PA8806801A1 (es)
PE (1) PE20091263A1 (es)
TW (1) TWI438202B (es)
UA (1) UA103013C2 (es)
UY (1) UY31513A1 (es)
WO (1) WO2009071650A2 (es)
ZA (1) ZA201004025B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009301131B2 (en) * 2008-10-07 2014-03-27 Janssen Sciences Ireland Uc New amide compounds as boosters of antivirals
US20120172368A1 (en) * 2009-09-03 2012-07-05 Koen Vandyck Bis-Benzimidazole Derivatives
US8759535B2 (en) 2010-02-18 2014-06-24 High Point Pharmaceuticals, Llc Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
CA2833006A1 (en) * 2011-04-22 2012-10-26 Merck Sharp & Dohme Corp. Taste-masked formulations of raltegravir
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug
CN104000824B (zh) * 2014-05-28 2016-07-06 中山大学 苯并五元杂环类化合物在制备抗hiv-1病毒药物中的应用
WO2016089648A1 (en) 2014-12-01 2016-06-09 Vtv Therapeutics Llc Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
CN105985356B (zh) * 2015-02-05 2018-06-22 四川大学 咪唑[2,1-b]噻唑衍生物及其制备方法和用途
AU2016375634B2 (en) 2015-12-22 2021-03-25 Kancera Ab Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity
AR114136A1 (es) 2017-10-10 2020-07-29 Hoffmann La Roche Compuestos heterocíclicos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037157A (en) * 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
AR037797A1 (es) 2001-12-12 2004-12-01 Tibotec Pharm Ltd Combinacion de inhibidores de proteasa dependientes del citocromo p450
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
CN101445493A (zh) * 2002-08-02 2009-06-03 泰博特克药品有限公司 广谱2-氨基-苯并噻唑磺酰胺类hiv蛋白酶抑制剂
AR053845A1 (es) * 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
WO2008022345A2 (en) * 2006-08-18 2008-02-21 Sequoia Pharmaceuticals, Inc. Compositions and methods for inhibiting cytochrome p450

Also Published As

Publication number Publication date
EA201070691A1 (ru) 2010-10-29
AU2008333165B2 (en) 2013-04-11
BRPI0821021A2 (pt) 2015-06-16
MY151005A (en) 2014-03-31
KR101624675B1 (ko) 2016-05-27
HK1149553A1 (en) 2011-10-07
NZ585652A (en) 2011-10-28
CL2008003639A1 (es) 2010-01-15
IL205489A (en) 2016-09-29
AR069595A1 (es) 2010-02-03
AP2804A (en) 2013-11-30
EP2235008B1 (en) 2016-03-16
PA8806801A1 (es) 2009-07-23
TWI438202B (zh) 2014-05-21
KR20100092489A (ko) 2010-08-20
MX2010006166A (es) 2010-10-05
WO2009071650A2 (en) 2009-06-11
EA019616B1 (ru) 2014-05-30
CN101878210A (zh) 2010-11-03
WO2009071650A3 (en) 2009-09-11
AP2010005285A0 (en) 2010-06-30
TW200938540A (en) 2009-09-16
CA2706155C (en) 2016-07-19
ZA201004025B (en) 2011-12-28
UA103013C2 (uk) 2013-09-10
JP2011506291A (ja) 2011-03-03
EP2235008A2 (en) 2010-10-06
PE20091263A1 (es) 2009-08-14
US8350048B2 (en) 2013-01-08
IL205489A0 (en) 2010-12-30
US20100305073A1 (en) 2010-12-02
CA2706155A1 (en) 2009-06-11
CN101878210B (zh) 2013-07-17
JP5509092B2 (ja) 2014-06-04
AU2008333165A1 (en) 2009-06-11

Similar Documents

Publication Publication Date Title
UY31513A1 (es) Compuestos amida como refuerzos de antivirales
DOP2017000261A (es) Derivados de ciclohexano sustituido con amido
CO2018002063A2 (es) Análogos novedosos de nucleósidos sustituidos en el anillo aromático bicíclico 6-6 para su uso como inhibidores de prmt5
PE20151067A1 (es) Inhibidores de autotaxina
CO6470845A2 (es) Derivados de pirimidina novedosos y su uso en el tratamiento del cancer y enfermedades adicionales
CO6270324A2 (es) Derivados de pirimidina para el tratamiento del asma epoc rinitis conjutivitis alergica dermatitis atopica cancer hepatitis b hepatitis c vih vph infecciones bacterianas y dermatosis
UY35263A (es) Compuestos terapéuticos
DOP2012000243A (es) Compuestos de sililo tricíclicos fusionados y uso de los mismos en la fabricación de medicamentos útiles en el tratamiento de enfermedades virales
UY33183A (es) Compuestos inhibidores de virus flaviviridae, composición farmaceutica que los contiene y su uso en la manufactura de un medicamento
GT201400111A (es) Triazolopiridinas sustituidas
GT201400031A (es) Derivados de 2-amino-4-(piridin-2-il)-5,6-dihidro-4h-1,3-oxazina y su uso como inhibidores de bace-1 y/o bace-2
DOP2015000245A (es) Derivados de 3-acetilamino-1 (fenil-heteroaril-aminocarbonil o fenil-heteroaril-carbonilamino) benceno para el tratamiento de desordenes hiperproliferativos
CR20150313A (es) Composiciones farmacéuticas
UY33735A (es) Compuestos antivirales
ECSP11010804A (es) Compuestos orgánicos
UY32673A (es) Nuevas pirimidinas, composiciones farmaceuticas que las contienen, procedimientos de preparaciones y su aplicacion como medicamentos
DOP2015000076A (es) Benzamidas
PE20151892A1 (es) Compuestos tetraciclicos sustituidos con heterociclo y metodos de uso de los mismos para el tratamiento de enfermedades viricas
BR112012009310A2 (pt) composto, e, composição farmacêutica
EA201101116A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
CO6321288A2 (es) Sales de compuestos inhibidores de vih
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
UY31016A1 (es) Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos
HN2010001537A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
CL2015002466A1 (es) Formulaciones de compuestos orgánicos